INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 720 | 0.0% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 720 | -98.2% | 0.00% | – |
Q1 2023 | $33 | -34.0% | 39,877 | +23.9% | 0.00% | – |
Q4 2022 | $50 | -99.9% | 32,186 | -20.1% | 0.00% | -100.0% |
Q3 2022 | $69,000 | -22.5% | 40,273 | -22.0% | 0.00% | 0.0% |
Q2 2022 | $89,000 | +18.7% | 51,629 | +146.6% | 0.00% | – |
Q1 2022 | $75,000 | +2.7% | 20,935 | +43.5% | 0.00% | – |
Q4 2021 | $73,000 | +35.2% | 14,590 | +92.3% | 0.00% | – |
Q3 2021 | $54,000 | +1250.0% | 7,589 | +1755.5% | 0.00% | – |
Q2 2021 | $4,000 | 0.0% | 409 | 0.0% | 0.00% | – |
Q1 2021 | $4,000 | +33.3% | 409 | +28.2% | 0.00% | – |
Q4 2020 | $3,000 | -70.0% | 319 | -64.7% | 0.00% | – |
Q3 2020 | $10,000 | +150.0% | 904 | +60.3% | 0.00% | – |
Q2 2020 | $4,000 | 0.0% | 564 | 0.0% | 0.00% | – |
Q1 2020 | $4,000 | +100.0% | 564 | +13.0% | 0.00% | – |
Q4 2019 | $2,000 | +100.0% | 499 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 499 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | -50.0% | 499 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 499 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -33.3% | 499 | 0.0% | 0.00% | – |
Q3 2018 | $3,000 | +50.0% | 499 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | 0.0% | 499 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | – | 499 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|